{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-006815","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2026-08-31T13:15:13+00:00","discovered_at":"2026-08-31T13:16:12.229719+00:00","generated_at":"2026-08-31T13:16:15.016824+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aethlon Medical: all pre-funded warrants exercised; 1,604,095 shares outstanding","bullets":["As of Aug 28, 2026, Aethlon Medical has 1,604,095 common shares outstanding.","All previously outstanding pre-funded warrants have been exercised.","CEO and CFO James B. Frakes signed the 8-K on Aug 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-006815","json":"https://secwatch.observer/filing/0001683168-26-006815.json","markdown":"https://secwatch.observer/filing/0001683168-26-006815.md","text":"https://secwatch.observer/filing/0001683168-26-006815.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/0001683168-26-006815-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T13:16:15.016824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}